Molecular pharmacology of VEGF-A isoforms: binding and signalling at VEGFR2

CJ Peach, VW Mignone, MA Arruda… - International journal of …, 2018 - mdpi.com
Vascular endothelial growth factor-A (VEGF-A) is a key mediator of angiogenesis, signalling
via the class IV tyrosine kinase receptor family of VEGF Receptors (VEGFRs). Although …

[HTML][HTML] Nitric oxide-releasing biomaterials for promoting wound healing in impaired diabetic wounds: State of the art and recent trends

R Ahmed, R Augustine, M Chaudhry, UA Akhtar… - Biomedicine & …, 2022 - Elsevier
Impaired diabetic wounds are serious pathophysiological complications associated with
persistent microbial infections including failure in the closure of wounds, and the cause of a …

[HTML][HTML] VEGFR1 signaling in retinal angiogenesis and microinflammation

A Uemura, M Fruttiger, PA d'Amore, S De Falco… - Progress in retinal and …, 2021 - Elsevier
Five vascular endothelial growth factor receptor (VEGFR) ligands (VEGF-A,-B,–C,-D, and
placental growth factor [PlGF]) constitute the VEGF family. VEGF-A binds VEGF receptors 1 …

Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy

HF Dvorak - Journal of clinical oncology, 2002 - ascopubs.org
Vascular endothelial growth factor A (VEGF-A), the founding member of the vascular
permeability factor (VPF)/VEGF family of proteins, is an important angiogenic cytokine with …

Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia

S Ahmad, A Ahmed - Circulation research, 2004 - Am Heart Assoc
Preeclampsia is an inflammatory disorder in which serum levels of vascular endothelial
growth factor (VEGF) and its soluble receptor-1 (sVEGFR-1, also known as sFlt-1) are …

Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics

EJ Tsai, DA Kass - Pharmacology & therapeutics, 2009 - Elsevier
Cyclic guanosine 3', 5'-monophosphate (cGMP) mediates a wide spectrum of physiologic
processes in multiple cell types within the cardiovascular system. Dysfunctional signaling at …

Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1

M Cudmore, S Ahmad, B Al-Ani, T Fujisawa, H Coxall… - Circulation, 2007 - Am Heart Assoc
Background—Preeclampsia is characterized clinically by hypertension and proteinuria.
Soluble Flt-1 (sFlt-1; also known as soluble vascular endothelial growth factor receptor-1 …

Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1

YM Kim, S Hwang, YM Kim, BJ Pyun, TY Kim… - Journal of biological …, 2002 - ASBMB
Endostatin, a fragment of collagen XVIII, is a potent anti-angiogenic protein, but the
molecular mechanism of its action is not yet clear. We examined the effects of endostatin on …

Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis

Z He, A Bateman - Journal of molecular medicine, 2003 - Springer
Progranulin (Pgrn) is a pluripotent secreted growth factor that mediates cell cycle
progression and cell motility. It activates the extracellular regulated kinases and …

[HTML][HTML] Role of nitric oxide in placental vascular development and function

BJ Krause, MA Hanson, P Casanello - Placenta, 2011 - Elsevier
Nitric oxide (NO) is one of the most pleiotropic signaling molecules at systemic and cellular
levels, participating in vascular tone regulation, cellular respiration, proliferation, apoptosis …